Captrust Financial Advisors Decreases Position in iShares Biotechnology ETF (NASDAQ:IBB)

Captrust Financial Advisors reduced its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 3.5% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 46,486 shares of the financial services provider’s stock after selling 1,680 shares during the period. Captrust Financial Advisors owned 0.09% of iShares Biotechnology ETF worth $6,768,000 at the end of the most recent quarter.

A number of other hedge funds have also made changes to their positions in the company. Darwin Wealth Management LLC purchased a new position in shares of iShares Biotechnology ETF in the third quarter worth about $29,000. Highline Wealth Partners LLC purchased a new position in iShares Biotechnology ETF in the 3rd quarter worth approximately $30,000. Bbjs Financial Advisors LLC acquired a new position in shares of iShares Biotechnology ETF during the 2nd quarter worth approximately $31,000. Ashton Thomas Securities LLC purchased a new stake in shares of iShares Biotechnology ETF in the third quarter valued at approximately $36,000. Finally, Voisard Asset Management Group Inc. acquired a new stake in shares of iShares Biotechnology ETF in the third quarter valued at approximately $59,000. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Price Performance

NASDAQ IBB opened at $141.73 on Tuesday. The stock’s fifty day moving average is $142.71 and its two-hundred day moving average is $142.09. iShares Biotechnology ETF has a fifty-two week low of $121.84 and a fifty-two week high of $150.57.

iShares Biotechnology ETF Dividend Announcement

The company also recently declared a dividend, which was paid on Monday, September 30th. Stockholders of record on Wednesday, September 25th were given a dividend of $0.2005 per share. The ex-dividend date of this dividend was Wednesday, September 25th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.